Aspirin resistance: What the cardiologist needs to know?

被引:10
作者
Tousoulis, Dimitris [1 ]
Siasos, Gerasimos [1 ]
Stefanadis, Christodoulos [1 ]
机构
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Unit 1, Athens 16675, Greece
关键词
Aspirin resistance; Antiplatelet treatment; Atherothrombosis; Cardiovascular events; CLINICAL READ-OUTS; ANTIPLATELET THERAPY; CONTROLLED TRIAL; CLOPIDOGREL; DISEASE; RISK; INHIBITION; MECHANISMS; PREVENTION; STROKE;
D O I
10.1016/j.ijcard.2008.12.074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
"Aspirin resistance" can be defined as the inability of aspirin to inhibit cyclooxygenase (COX)-1 dependent thromboxane (TX) A2 production, and consequently TX A2-dependent platelet functions. Several laboratory methods have been proposed, to evaluate platelets' resistance to antiplatelet treatment (bleeding time, light transmission aggregation, impedance aggregation, platelet function analyser, rapid platelet function assay, TXB2, flow cytometry). However, all these methods have their advantages intrinsic limitations. Although aspirin resistance appears to be linked to worse long-term outcomes in cardiovascular disease patients, clinical treatment of aspirin resistance, including an increased aspirin dose or the addition of other antiplatelet drugs, is not often effective. Further studies needed to elucidate the appropriate management of aspirin resistance. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:153 / 156
页数:4
相关论文
共 22 条
[1]   Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].
Bhatt, DL ;
Fox, KAA ;
Hacke, W ;
Berger, PB ;
Black, HR ;
Boden, WE ;
Cacoub, P ;
Cohen, EA ;
Creager, MA ;
Easton, JD ;
Flather, MD ;
Haffner, SM ;
Hamm, CW ;
Hankey, GJ ;
Johnston, SC ;
Mak, KH ;
Mas, JL ;
Montalescot, G ;
Pearson, TA ;
Steg, PG ;
Steinhubl, SR ;
Weber, MA ;
Brennan, DM ;
Fabry-Ribaudo, L ;
Booth, J ;
Topol, EJ ;
Frye, RL ;
Amarenco, P ;
Brass, LM ;
Buyse, M ;
Cohen, LS ;
DeMets, DL ;
Fuster, V ;
Hart, RG ;
Marler, JR ;
McCarthy, C ;
Schoemig, A ;
Lincoff, AM ;
Brener, SJ ;
Sila, CA ;
Albuquerque, A ;
Aroutiounov, G ;
Artemiev, D ;
Atkeson, BG ;
Bartel, T ;
Basart, DCG ;
Lima, AB ;
Belli, G ;
Bordalo e Sa, AL ;
Bosch, X .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717
[2]  
BUCHANAN MR, 1995, CAN J CARDIOL, V11, P221
[3]   Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection [J].
Cattaneo, M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 :230-237
[4]   Ethical authorship and publishing [J].
Coats, Andrew J. S. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) :149-150
[5]   PlA2 polymorphism and efficacy of aspirin [J].
Cooke, GE ;
Bray, PF ;
Hamlington, JD ;
Pham, DM ;
Goldschmidt-Clermont, PJ .
LANCET, 1998, 351 (9111) :1253-1253
[6]   Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial [J].
Diener, HC ;
Bogousslavsky, J ;
Brass, LM ;
Cimminiello, C ;
Csiba, L ;
Kaste, M ;
Leys, D ;
Matias-Guiv, J ;
Rupprecht, HJ .
LANCET, 2004, 364 (9431) :331-337
[7]   Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities [J].
Grosser, T ;
Fries, S ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :4-15
[8]   EFFECTS OF ACETYLSALICYCLIC ACID IN STROKE PATIENTS EVIDENCE OF NONRESPONDERS IN A SUBPOPULATION OF TREATED PATIENTS [J].
GROTEMEYER, KH .
THROMBOSIS RESEARCH, 1991, 63 (06) :587-593
[9]   A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease [J].
Gum, PA ;
Kottke-Marchant, K ;
Welsh, PA ;
White, J ;
Topol, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) :961-965
[10]   Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review [J].
Hovens, Marcel M. C. ;
Snoep, Jaapjan D. ;
Eikenboom, Jeroen C. J. ;
van der Bom, Johanna G. ;
Mertens, Bart J. A. ;
Huisman, Menno V. .
AMERICAN HEART JOURNAL, 2007, 153 (02) :175-181